All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Viking Therapeutics Inc., of San Diego, said the underwriters for its recent IPO exercised in full their option to purchase an additional 450,000 shares at the IPO price of $8 per share.